Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival.
about
Design, biological evaluation and 3D QSAR studies of novel dioxin-containing pyrazoline derivatives with thiourea skeleton as selective HER-2 inhibitors.Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor olaparib by a dominant negative effect.Oncolytic viruses: emerging options for the treatment of breast cancer.The second annual conference of International ovarian cancer consortium and the symposium on tumor microenvironment and therapeutic resistance.
P2860
Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Human Epidermal Growth Factor ...... t Breast Cancer Cell Survival.
@ast
Human Epidermal Growth Factor ...... t Breast Cancer Cell Survival.
@en
type
label
Human Epidermal Growth Factor ...... t Breast Cancer Cell Survival.
@ast
Human Epidermal Growth Factor ...... t Breast Cancer Cell Survival.
@en
prefLabel
Human Epidermal Growth Factor ...... t Breast Cancer Cell Survival.
@ast
Human Epidermal Growth Factor ...... t Breast Cancer Cell Survival.
@en
P2093
P2860
P356
P1476
Human Epidermal Growth Factor ...... t Breast Cancer Cell Survival.
@en
P2093
Basabi Rana
Clodia Osipo
Gautam Sondarva
Guri Tzivion
Navin Viswakarma
Rakesh Sathish Nair
P2860
P304
21705-21712
P356
10.1074/JBC.M115.655563
P407
P50
P577
2015-07-07T00:00:00Z